
403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
A First-Of-Its-Kind Non-Surgical Procedure Is Now In Clinical Trials
EINPresswire/ -- Type 2 diabetes is one of the most significant health challenges in the U.S., affecting more than 34 million Americans — with nearly 9 million undiagnosed. Left unmanaged, the disease can lead to serious complications including heart disease, kidney failure, vision loss, nerve damage, and amputation.
While there’s no cure for Type 2 diabetes, researchers at Endogenex - a clinical-stage medical device company - are studying a new non-surgical procedure that uses controlled electric pulses to regenerate healthy cells in the duodenum, the top part of the small intestine. By restoring the gut, the treatment aims to slow or even stop disease progression.
Dr. Richard Pratley discusses why Type 2 diabetes is a growing health concern in the U.S., explain how the new investigational procedure works, and share early study results. They also provide details on how people with Type 2 diabetes nationwide can participate in the research.
For more information, please visit and .
While there’s no cure for Type 2 diabetes, researchers at Endogenex - a clinical-stage medical device company - are studying a new non-surgical procedure that uses controlled electric pulses to regenerate healthy cells in the duodenum, the top part of the small intestine. By restoring the gut, the treatment aims to slow or even stop disease progression.
Dr. Richard Pratley discusses why Type 2 diabetes is a growing health concern in the U.S., explain how the new investigational procedure works, and share early study results. They also provide details on how people with Type 2 diabetes nationwide can participate in the research.
For more information, please visit and .

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Crypto Market Update: Pepeto Advances Presale With Staking Rewards And Live Exchange Demo
- Kucoin Appeals FINTRAC Decision, Reaffirms Commitment To Compliance
- Cregis And Sumsub Host Web3 Compliance And Trust Summit In Singapore
- Chartis Research And Metrika Release Comprehensive Framework For Managing Digital Asset Risk
- Nodepay Launches Crypto's Largest Prediction Intelligence Platform
- Schoenherr Opens London Liaison Office As Gateway To Central Eastern Europe
Comments
No comment